NewHydrogen secures $3M equity line from GHS Investments
What's the deal? NewHydrogenDealroom has a profile for this one. Try Dealroom → has signed a $3 million equity financing agreement with GHS InvestmentsDealroom has a profile for this one. Try Dealroom →, giving the company the right — but not the obligation — to sell newly issued common stock to the investor over a 24-month period. The deal, dated September 8, 2026, was disclosed in a Form 8-K filed three days later.
How the facility works: Once a registration statement on Form S-1 is declared effective by the Securities and Exchange Commission, NewHydrogen can deliver "put" notices requiring GHS to buy shares. The purchase price is set at a discount to the lowest traded price over the preceding 10 trading days.
NewHydrogen issued GHS 980,713 restricted shares as commitment shares at signing, priced at 95% of the volume weighted average price the trading day before execution. The company must file the S-1 within 30 days of signing.
What's the endgame? NewHydrogen said proceeds will fund general corporate and working capital purposes. The facility runs until the earlier of 24 months after effectiveness or until GHS has bought $3,000,000 in shares.
What could go wrong? Because pricing is set at a discount to the lowest traded price in the preceding 10-day window, the facility mechanically issues more shares as the stock falls. NewHydrogen acknowledges the structure carries a "potential dilutive effect on the shareholders," with its obligation to issue shares described as "absolute and unconditional regardless of the dilutive effect," subject to stated caps.
The signal: Equity lines of credit give small-cap firms flexible, on-demand access to capital without a fixed raise — but at the cost of dilution risk when share prices decline. For NewHydrogen, the $3 million ceiling underscores a modest, cushion-building deal rather than a major capital event.
Read more: minichart.com.sg
Image credit: Idaho National Laboratory
